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Abstract
Background: Hormone-sensitive lipase (HSL) is expressed predominantly in adipose tissue, where it plays an important role
in catecholamine-stimulated hydrolysis of stored lipids, thus mobilizing fatty acids. HSL exhibits broad substrate specificity
and besides acylglycerides it hydrolyzes cholesteryl esters, retinyl esters and lipoidal esters. Despite its role in fatty acid
mobilization, HSL null mice have been shown to be resistant to diet-induced obesity. The aim of this study was to define
lipid profiles in plasma, white adipose tissue (WAT) and liver of HSL null mice, in order to better understand the role of this
multifunctional enzyme.
Methodology/Principal Findings: This study used global and targeted lipidomics and expression profiling to reveal
changed lipid profiles in WAT, liver and plasma as well as altered expression of desaturases and elongases in WAT and liver
of HSL null mice on high fat diet. Decreased mRNA levels of stearoyl-CoA desaturase 1 and 2 in WAT were consistent with a
lowered ratio of 16:1n7/16:0 and 18:1n9/18:0 in WAT and plasma. In WAT, increased ratio of 18:0/16:0 could be linked to
elevated mRNA levels of the Elovl1 elongase.
Conclusions: This study illustrates the importance of HSL for normal lipid metabolism in response to a high fat diet. HSL
deficiency greatly influences the expression of elongases and desaturases, resulting in altered lipid profiles in WAT, liver and
plasma. Finally, altered proportions of palmitoleate, a recently-suggested lipokine, in tissue and plasma of HSL null mice,
could be an important factor mediating and contributing to the changed lipid profile, and possibly also to the decreased
insulin sensitivity seen in HSL null mice.
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Introduction
Obesity is a growing health problem globally, predisposing
individuals to disorders such as type 2 diabetes, cardiovascular
disease and certain cancers. Understanding molecular events of
fatty acid metabolism in tissues regulating lipid-fluxes e.g. adipose
tissue and liver are of great importance in order to understand and
reverse the progression of this disease.
HSL is a key enzyme in fatty acid mobilization in white
adipose tissue (WAT). It has a wide tissue distribution and is,
besides WAT and brown adipose tissue (BAT), expressed also in
steroidogenic tissues, skeletal muscle, macrophages, pancreatic
b-cells and liver [1]. Its role in catecholamine-stimulated
hydrolysis of stored triacylglyceride (TAG) and, in particular,
diacylglyceride has been demonstrated in studies of HSL-null
mice [2,3]. Despite its prominent role in lipolysis, HSL-null
mice are not obese and exhibit a remarkable resistance to
development of obesity following challenge with a long-term
high fat diet (HFD) [4,5]. The resistance to diet-induced obesity
is accompanied by impaired adipogenesis [4,5] and attainment
of brown adipocyte features of WAT [4], suggesting that HSL
plays additional, yet unexplored, roles in adipose tissue. HSL
exhibits broad substrate specificity and besides acylglycerides it
hydrolyzes cholesteryl esters, retinyl esters, lipoidal esters and
water-soluble esters. The biological significance of these other
activities, however, is poorly understood. We have recently
shown that HSL is the major retinyl ester hydrolase of white and
brown adipocytes [6]. In its absence retinoid metabolism is
perturbed, potentially leading to failure to provide retinoic acid
for signaling events that are crucial for adipogenesis and
determination of adipocyte fate. Thus, in addition to its key
role in energy homeostasis, HSL appears to play an important
role in the generation of lipids for transcriptional regulation and
various lipid signaling events.
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29It has been reported that metabolic diseases, such as diabetes
and obesity, induce changes in hepatic lipid composition by
controlling the function of key transcription factors that in turn
affect elongase and desaturase expression [7]. This highlights the
importance of fatty acid elongation and desaturation in managing
hepatic lipid composition in response to dietary status.
Stearoyl-CoA desaturases (SCDs) are ER proteins that
catalyze the delta-9-cis desaturation of saturated fatty acids,
preferentially 16:0 and 18:0. At present time there are four SCD
isoforms described in mouse [8]. Whereas expression of SCD3
and 4 is restricted mainly to skin and heart, respectively, a wider
tissue distribution is seen for SCD1 and 2. Fatty acid analyses
have shown that while mouse SCD3 uses only 16:0 as a
substrate [9] the other isoforms desature both 18:0 and 16:0.
This, together with tissue distribution, point towards distinct
physiological roles of the different SCD. Both SCD1 and 2 are
expressed in adipocytes in a differentiation-dependent pattern,
where a massive increase of SCD1 and a moderate increase of
S C D 2c a nb es e e na f t e rd i f f e r e n t i a t i o no f3 T 3 - L 1p r e a d i p o c y t e s
to adipocytes [10,11]. Also, SCD2 mRNA expression is
uniquely increased (44-fold) in adipocytes from mice fed a
HFD, with only slight regulation of SCD1 expression [11].
Further, it was recently reported that SCD2, but not SCD1, is
required for adipogenesis and maintenance of the adipocyte-
specific gene expression in 3T3-L1 adipocytes. SCD1 deficient
mice are resistant to HFD-induc e do b e s i t ya n da r ep r o t e c t e d
against liver steatosis [12]. It has been suggested that
desaturation of saturated fatsb yS C D 1i sa ne s s e n t i a ls t e p
mediating their induction of lipogenesis [13].
Elongase enzymes add two carbon units to the carboxyl end of a
fatty acid using malonyl-CoA and fatty acyl-CoA as substrates.
Seven distinct fatty acid elongase (Elovl) subtypes are present in
the mouse, rat and human genomes (www.ensembl.org), with
Elovl1, 3, 6 and 7 preferring saturated and monounsaturated fatty
acids and Elovl2, 4 and 5 being selective for polyunsaturated fatty
acids [14]. Moreover, Elovls display tissue specificity where Elovl1
appears to be expressed ubiquitously [7,14]. Elovl3 is expressed
mainly in the skin but is also detected in WAT and BAT. Elovl6 is
expressed at low levels in several tissues including liver. Finally,
Elovl5 is the most abundant elongase in many tissues.
Under normal circumstances, there appears to be a tightly
coordinated regulation between glycolysis, de novo lipogenesis,
elongation and desaturation, where excess glucose, channeled to
de novo lipogenesis is subsequently elongated and desaturated
yielding 18:1, a fatty acid readily stored in TAG and accumulated
in livers of obese mice [7].
The aim of the present study was to investigate changes in lipid
metabolism of HSL null mice on a HFD, to better understand the
role of HSL for these processes. To this end, we performed a
targeted lipid analysis of TAG in WAT, liver and plasma and of
non-esterified fatty acids (NEFA) in plasma using gas chroma-
tography, as well as a global lipid analysis of plasma using
shotgun lipidomics. In addition, we used real-time quantitative
PCR technique to measure the gene expression of enzymes
involved in desaturation and elongation of fatty acids in WAT,
BAT and liver
This study illustrates the importance of HSL for normal lipid
metabolism in response to a HFD. HSL deficiency greatly
influences the expression of elongases and desaturases, resulting
in altered lipid profiles in WAT, liver and plasma. Finally, altered
levels of palmitoleate, a recently suggested lipokine, in tissue and
plasma of HSL null mice, could be an important factor mediating
and contributing to the changed lipid profile, and possibly also to
the decreased insulin sensitivity seen in HSL null mice.
Materials and Methods
Animal experiments
The study was reviewed and approved by the Ethical
Committee in Malmo ¨/Lund, Lund, Sweden (license no. M202-
08) and is in accordance with the Council of Europe Convention
(ETS 123). HSL null mice were generated by targeted disruption
of the HSL gene in SV129-derived embryonic stem cells as
described elsewhere [15]. Animals used were from the same
embryonic stem cell colony and animals in the different groups
were littermates and had a mixed genetic background from the
inbred strains C57BL/6J and SV129 [2]. Both male and female
mice were studied. The animals were maintained in a tempera-
ture-controlled room (22oC) on a 12-h light-dark cycle. The diet
studies were initiated by feeding mating mice a high fat diet (HFD)
(58% energy from fat) (Research Diets; products no D12309 and
D05021605). The mice were maintained on a HFD, provided ad
libitum, until the age of 5 months, after which the mice were killed
and tissues dissected. Collected tissues were rapidly dissected, and
tissues and plasma were snap frozen and stored in liquid nitrogen
before analyses. Blood samples were drawn by retro-orbital
puncture. Tissues and plasma were collected after an overnight
fast (12–6 h). Gene expression was analyzed using real-time
quantitative PCR technique, on RNA extracted from isolated
periovarial white adipocytes, BAT and liver from female mice
after an overnight fast (12–16 h).
Preparation of isolated white adipocytes
Adipocytes from periovarial WAT were isolated after incuba-
tion in Krebs-Ringers solution (pH 7.4) supplemented with 3.5%
BSA, 2 mM glucose, 200 nM adenosine and collagenase (1 mg/
ml; Sigma) in a shaking incubator at 37uC for ,60 min according
to a modification of the Rodbell method [16]. The digested tissue
was filtered and the isolated cells were washed twice in Krebs-
Ringer buffer (pH 7.4) with 1% BSA, 2 mM glucose and 200 nM
adenosine by allowing the isolated adipocytes to float to the surface
and then aspirate the underlying buffer.
Tissue homogenate preparation
Periovarial WAT was homogenized in 0.25 M sucrose, 1 mM
EDTA pH 7.0, 1 mM dithiothreitol, 20 mg/ml leupeptin, 10 mg/
ml antipain, 1 mg/ml pepstatin A using a glass/teflon homogenizer
(10–20 strokes), followed by a centrifugation at 10 000 g for
25 min at 4uC. The infranatant fraction was used for western blot
detection of FAS. The pellet fraction was solubilized in
homogenization buffer containing 5% SDS for 30 min at 50uC,
and was used for western blot detection of SREBP1. Protein
determination was performed using the BCA assay (Pierce).
RNA preparation and Real-time quantitative PCR (rtPCR)
Total RNA was isolated using RNeasy Lipid Tissue Mini Kit
(Qiagen) according to the manufacturer’s recommendations. Total
RNA (1 mg) was treated with DNase I (DNase I amplification
grade, Invitrogen) and then reversely transcribed using random
hexamers (Amersham Biosciences) and SuperScript
TMII RNaseH
reverse transcriptase (Invitrogen Life Technologies) according to
the manufacturer’s recommendations. The cDNA was used in
quantitative PCR reactions using Taqman chemistry (assays-on-
demand, Applied Biosystems) with an ABI 7900 system (Applied
Biosystems). The assay Ids of the Taqman probes are listed below.
Relative abundance of mRNA was calculated with normalization
by geometric averaging of two internal control genes (TATA box
binding protein (TBP) and ribosomal protein S29 (RPS29) for
adipocytes and using three internal control genes (glyceraldehyde
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phosphoribosyl transferase (HPRT) 1 and RPS29) for liver samples
[17].
Primers used in real-time quantitative PCR experiments
List of assays using Taqman probes:
SCD1 (Assays-on-demand, Mm00772290_m1)
SCD2 (Assays-on-demand, Mm00485951_g1)
Elovl1 (Assays-on-demand, Mm00517077_m1 and Mm01188-
316_g1 (liver))
Elovl3 (Assays-on-demand, Mm00468164_m1 and Mm0119-
4164_m1 (liver))
Elovl5 (Assays-on-demand, Mm00506717_m1)
Elovl6 (Assays-on-demand, Mm00851223_s1 and Mm042-
09852_g1 (liver))
TBP (Assays-on-demand, Mm00446973_m1)
RPS29 (Assays-on-demand, Mm02342448_gH)
GAPDH (Assays-on-demand, Mm99999915_g1)
HPRT1 (Assays-on-demand, Mm01545399_m1)
Western blot analysis
Periovarial WAT was homogenized and 25–50 mg of total
protein were resolved by SDS-PAGE and electroblotted onto
nitrocellulose membranes (HyBond-c extra, Amersham Pharmacia
Biotech). Primaryantibodiesused wereSREBP1, fattyacid synthase
(FAS) (Santa Cruz Biotechnology), b-actin and a-tubulin (Sigma-
Aldrich). Actin and tubulin were used as loading controls.
Secondary antibodies were horseradish peroxidase-conjugated
anti-rabbit IgG (SREBP1 and FAS) and anti-mouse IgG (a-tubulin
and b-Actin) (Amersham). Western blot analysis was performed
using a chemiluminescence system (Luminol) and detection was
made usinga CCD-camera (LAS 1000, Fuji). Relative protein levels
were calculated after normalization to the loading control.
Analysis of fatty acid composition of plasma NEFA,
plasma TAG, WAT TAG and liver TAG
Lipids from plasma or homogenized WAT and liver were
extracted in 2:1 chloroform: methanol (v/v) [18]. The solvent
layer was evaporated to dryness and lipid classes were separated by
solid-phase extraction [19] and fatty acid methyl esters (FAME)
prepared using acidic methanol before analyzing the samples by
gas chromatography [20]. Fatty acids were identified using specific
fatty acid methyl esters and verified on each run using a standard
containing methyl esters of fatty acids ranging from chain length 6
to 24 (Sigma-Aldrich Company Ltd, Poole, Dorset, UK). In
addition, a methyl ester standard of known fatty acid composition
was run with every set of samples (AOCS std#6, Thames Restek
UK Ltd, Saunderton, Bucks, UK) to check correct identification of
sample peaks and performance of the instrument. The mean and
between-run precision (CV (%), n=30) was as follows 16:0 29.7
(0.62), 16:1n7 30 (0.96), 18:0 14.0 (0.79) and 18:1n9 41.7 (0.52). A
quality control sample was also run with each set of samples. This
was a mixture of fatty acids (Sigma-Aldrich Company Ltd) and
TG (MaxEPA fish oil, Seven Seas Ltd, Marfleet, Hull UK) that
was extracted, separated and methylated alongside each set of
samples. The mean and between-assay precision (CV (%), n=33)
was as follows for TG 16:0 25 (4.0), 16:1n7 12 (5.7), 18:0 5.9 (6.2)
and 18:1n9 16.4 (4.2). The mean and within-assay precision (CV
(%), n=22) was calculated on replicate measurements of human
adipose tissue as follows 16:0 22.5 (1.6), 16:1n7 5.3 (1.4), 18:0 4.4
(2.3) and 18:1n9 46.0 (1.03). On a GC, the peak area is
proportional to the weight of the fatty acid, and using the peak
areas, results are expressed as weight % (g/100 g total fatty acids).
Shotgun screening of plasma lipidome
Plasma lipid extraction was performed as previously described
[21]. In brief,5 mL of plasmawere placed into an eppendorf tube and
350 mL of a standard mixture consisting of the following lipids was
added: cholesteryl heptadecanoate (CE 17:0), 3.6 nmol; heptadeca-
noyl sphingomyelin (SM 17:0), 0.9 nmol; 1,2-di-O-hexadecyl-sn-
glycero-3-phosphocholine (PC-O12:0/-O12:0), 3.2 nmol; 1,2-di-O-
phytanyl-sn-glycero-3-phosphoethanolamine (PE-O16:0/-O16:0),
1.3 nmol; 1-lauroyl-2-hydroxy-sn-glycero-3-phosphocholine (LPC
12:0), 3.0 nmol (Avanti Polar Lipids Inc, Alabaster, AL), trilaurin
(TAG 12:0), 2.9 nmol and dilaurin (DAG 12:0), 0.4 nmol
(Larodan, Fine Chemicals, Malmo ¨, Sweden). Then 350 mLo f
methyl-tert-butylether (MTBE) (Sigma-Aldrich) were added and
the samples were shaken at 4uC for 1 h. Afterwards 150 mLo f
water (LC-MS grade) (Merck, Darmstadt, Germany) were added,
followed by shaking at 4uC for 10 min and centrifugation for
5 min at 4,000 rpm on a minispin centrifuge (Eppendorf,
Hamburg, Germany). The upper phase was transferred into a
glass vial and stored at 220uC until analysis. Mass spectrometric
analysis was performed on a LTQ Orbitrap (Thermo Fisher
Scientific, Waltham, MA) coupled to a TriVersa NanoMate
robotic nanoflow ion source (Advion BioSciences, Ithaca, NY) as
previously described [22]. Samples were analyzed in duplicate.
Lipids were identified and quantified using the LipidXplorer
software [22] and lipid species of the following lipid classes were
recognized and quantified: TAG, diacylglycerides (DAG),
cholesteryl esters (Chol-FA), sphingomyelins (SM), phosphatidyl-
cholines (PC), phosphatidylcholine ethers (PC-O), lysophophati-
dylcholines (LPC), phosphatidylethanolamines (PE) and phospha-
tidylethanolamine ethers (PE-O). Identification of the different
lipid species was based on MS survey scans acquired in positive
ion mode in the Orbitrap analyzer at a target mass resolution of
100,000 using a mass accuracy of better than 4 ppm and an
occupancy threshold of at least 2,000 counts per peak area. Only
peaks with an intensity signal at least 5 times above the blank
were further considered. Species were quantified by normalizing
the intensities of their peaks to the intensity of the peaks of
internal standards spiked into the sample prior to lipid extraction.
Glucose and Insulin Tolerance Test
Intravenous glucose tolerance test (IGTT) and insulin tolerance
test (ITT) were performed on female mice on 18 weeks HFD (ITT)
or 24 weeks HFD (IGTT).
For the IGTT, D-glucose (1 g/kg) was injected into the tail vein
of anesthetized mice (midazolam (0.4 mg/mouse; DormicumH;
Hoffmann-La Roche) and a combination of fluanison (0.9 mg/
mouse) and fentanyl (0.02 mg/mouse; HypnormH; Janssen,
Beerse, Belgium)) after 6 h daytime food withdrawal. In the
ITT, 0.75 milliunits/g human insulin (Actrapid; Novo Nordisk,
Bagsvaerd, Denmark) was given intraperitoneally to non-fasted
anesthetized mice. Plasma glucose and insulin levels were
determined in retro-orbital blood samples collected at the time
points indicated in the figures.
Statistics
Data are expressed as mean 6 SEM unless otherwise stated.
Statistical analysis was made using a non-parametric Mann-
Whitney U test. Data were considered significant if p,0.05.
p,0.05=*, p,0.01=**, p,0.001=***. Univariate statistical
analyses were performed with the Graph Pad Prism software
version 4 (GraphPad, San Diego, CA). Multivariate statistical
methods were also applied to the lipidomics data set using
SIMCA-P+12.0 (Umetrics, Umea ˚, Sweden). An Orthogonal
Partial Least Squares-Discriminant Analysis (OPLS-DA) was
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lipid species between the two studied groups.
Results
Decreased desaturation of fatty acids in adipose tissue,
plasma and liver of HSL null mice on HFD
Confirming previous results of a dramatic decrease in SCD1 at
the protein level in WAT from HSL null mice [4], we here show
decreased SCD1 mRNA levels (0.45, p,0.001) in isolated white
adipocytes of HSL null mice (Figure 1A). Also, the mRNA level
of SCD2 was dramatically decreased (0.24, p,0.001) in isolated
white adipocytes of HFD-fed HSL null mice compared to wildtype
littermates (Figure 1B). This is in contrast to the liver, where a
significant increase in the expression level of SCD1 [23] and
SCD2 (2.98, p,0.01) (Table 1) was seen in HSL null mice in the
fasted state. In BAT, mRNA levels of SCD1 and 2 were
unchanged between the two genotypes (Table 1).
Fatty acid ratios in tissue or plasma lipid classes are frequently
used to mirror enzyme activity of e.g. desaturases and elongases.
Moreover, fasting plasma NEFA and TAG may reflect enzyme
activities in adipose tissue and liver, respectively [24]. Accord-
ingly, decreased expression of D9-desaturases in white adipocytes
was reflected in decreased ratios of 16:1n7/16:0 (0.73, p,0.01)
and 18:1n9/18:0 (0.82, p,0.01) fatty acids in WAT TAG from
HFD-fed HSL null mice (Figure 2A,B). In plasma, decreased
desaturase activity in WAT resulted in lower ratios of 16:1n7/
16:0 (0.66, p,0.05) and 18:1n9/18:0 (0.66, p,0.01) NEFA
(Figure 2C,D). The lowered ratio of 16:1n7/16:0 fatty acids
(0.70, p,0.05) seen in plasma TAG (Figure 2E) and the
markedly lower ratio of 16:1n7/16:0 (0.53, p,0.01) in the liver
(Figure 2F), suggest a decreased desaturase activity in the liver of
HSL null mice, whereas SCD1 mRNA is in fact increased as
above. Such a discrepancy between SCD1 expression and
16:1n7/16:0 ratio has been reported previously [25], and could
be the result of altered expression and activity of other enzymes
involved in lipid metabolism, e.g. elongases. Decreased propor-
tions of 16:1n7 palmitoleic acid were seen in WAT TAG (0.74,
p,0.01), plasma NEFA (0.70, p,0.05) and plasma TAG (0.63,
p,0.05) of HSL null mice on a HFD (Table 2). Also,
proportions of 16:0, 18:0 and 18:1n9 in WAT TAG, plasma
NEFA and plasma TAG in HSL null mice compared to wildtype
are listed in Table 2.
Altered expression of elongases in adipocytes HSL null
mice on HFD
Elovl1 is commonly regarded as a housekeeping gene in many
tissues and is often seen expressed at steady levels [14]. When
investigating the expression levels of different elongases in isolated
adipocytes from WAT, a striking result was a significant increase
in the mRNA levels of Elovl1 (1.56, p,0.001) in adipocytes from
HSL null mice fed a HFD (Figure 3A). In contrast, decreased
expression levels of Elovl3 (0.43, p,0.05), Elovl5 (0.69, p,0.001)
and Elovl6 (0.27, p,0.001) were seen in adipocytes from HSL null
mice on a HFD (Figure 3B–D). In the liver, increased levels of
Elovl1 (1.24, p,0.05) and 3 (1.85, p=0.057) were seen in HSL
null mice on HFD, whereas the levels of Elovl 5 and 6 were not
significantly changed between the two genotypes (Table 1).
Similar to WAT, increased levels of Elovl1 (2.05, p,0.01) and
decreased levels of Elovl3 (0.26, p,0.05) were also observed in
BAT of HSL null mice fed HFD (Table 1). However, in BAT,
levels of Elovl5 and 6 were unchanged between the two genotypes
(Table 1).
Figure 1. Decreased expression of 9-desaturases in white adipocytes from HSL null mice. Level of mRNA of SCD1 (A) and SCD2 (B)
analyzed with real-time quantitative PCR in isolated adipocytes from periovarial WAT from 5 months old, HFD-fed wildtype and HSL null mice after an
overnight fast (n=11). Values given are mean 6 SEM, ***p,0.001, analyzed with Mann-Whitney U tests.
doi:10.1371/journal.pone.0021603.g001
Table 1. Gene expression analysis in liver and BAT of
wildtype and HSL null mice.
Liver BAT
Gene Wildtype HSL null P-value Wildtype HSL null P-value
SCD1 See [23] 0.8960.14 0.8460.20 1.00
SCD2 0.3560.01 1.0360.20** 0.008 0.9460.13 0.8960.10 0.84
Elovl1 0.8460.03 1.0460.05* 0.016 0.3760.01 0.7660.09** 0.008
Elovl3 0.3560.06 0.5460.04 0.057 0.7960.13 0.2060.07* 0.016
Elovl5 0.7260.10 0,5360.11 0.13 0.7860.05 0.7760.07 1.00
Elovl6 0.8860.16 0.8260.09 0.73 0.9160.13 0.8360.17 0.69
Data were generated using Real-time quantitative PCR on female mice after
HFD followed by an overnight fast (12 h). Values given are arbitrary means 6
SEM, n=5. Relative mRNA quantities were normalized by geometric averaging
of three internal control genes (RPS29, HPRT1 and GAPDH) for the liver and two
internal control genes (RPS29 and TBP) for BAT. Differences between the two
genotypes were analyzed using a non-parametric Mann-Whitney U-test. Data
were considered significant if p,0.05.
*p,0.05,
**p,0.01.
doi:10.1371/journal.pone.0021603.t001
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liver from HSL null mice on HFD
Elevated ratios of 16:0/14:0 (1.26, p,0.001) and 18:0/16:0
(1.22, p,0.01) fatty acids were seen in WAT TAG from HFD-fed
HSL null mice (Figure 4A,B). Similarly, in plasma from HFD-fed
HSL null mice, a higher ratio of both 18:0/16:0 (1.21, p,0.05)
NEFA (Figure 4C), and 20:0/18:0 (2.70, p=0.067) and 20:1n9/
18:1n9 (5.57, p,0.05) fatty acids in plasma TAG (Figure 4D,E)
was observed. In the liver TAG from HFD-fed HSL null mice,
elevated ratios of 18:0/16:0 (1.45, p,0.05) and 20:1n9/18:1n9
(2.06, p,0.01) fatty acids were seen (Figure 4F,G).
Dramatic reduction of plasma TAG molecular species in
HSL null mice on HFD
A total of 113 lipid species belonging to 9 different lipid classes
were identified and quantified in mouse plasma by shotgun
lipidomics, of which 35 TAGs, 3 DAGs, 4 Chol-FAs, 12 SMs, 16
PCs, 11 PC-Os, 6 LPCs, 16 PEs and 10 PE-Os (Figure 5). Most
of the changes in the lipid profile of HSL null mice compared to
wildtype occurred within the TAG lipid class where the plasma
content of 28 out of the 35 analyzed TAG species was diminished
(p,0.05 and p,0.01) and most of the regulated TAG species were
decreased by more than 50%. Other affected lipid species included
SM 38:1, the levels of which were halved in HSL null mice
compared to wildtype (p,0.05). PE species tended to be elevated
in HSL null mice compared to control, e.g. PE36:4 was increased
2.5 fold, and statistical significance was reached for 5 PE species
out of the 16 measured (p,0.05 and p,0.01).
Apart from the univariate data analysis, OPLS-DA of the
plasma lipidomics data was conducted to establish the discrimi-
nant lipid species between the two groups with the 113 identified
lipid species included in the analysis as variables. A clear
Figure 2. Decreased desaturation of fatty acids in WAT, plasma and liver from HSL null mice. Ratios of 16:1n7/16:0 (A) and 18:1n9/18:0
(B) fatty acids in epididymal WAT TAG from 5 months HFD-fed HSL null mice (n=6–12). Ratios of 16:1n7/16:0 (C) and 18:1n9/18:0 (D) fatty acids in
plasma NEFA (n=6–10) and 16:1n7/16:0 (E) fatty acids in plasma TAG (n=6–11) in 5 months old HFD-fed male wildtype and HSL null mice. (F) Ratios
of 16:1n7/16:0 fatty acids in liver TAG from female mice (n=6–7). Tissues and plasma were collected from mice after an overnight fast. Values given
are mean 6 SEM, *p,0.05, **p,0.01, analyzed with Mann-Whitney U tests.
doi:10.1371/journal.pone.0021603.g002
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littermates was achieved (Figure 6A). Thirty-seven lipid species
contributed the most to the separation between the two genotypes
(Figure 6B,C). Several TAG species as well as SM 38:1 were
found to be less abundant (Figure 6B), while several PE species
were found to be elevated (Figure 6C) in HSL null mice on HFD
vs. wildype littermates, supporting the results from the univariate
data analysis.
Decreased protein levels of lipogenic genes in WAT of
HSL null mice fed a HFD
To further characterize the metabolic state and the capacity of
WAT to generate endogenous fatty acids, protein levels of key
enzymes in de novo lipogenesis were analyzed in WAT of HSL
null mice fed a HFD. Decreased mRNA levels of SREBP1c and
FAS has previously been demonstrated in WAT [5] and in isolated
adipocytes of HSL null mice on a HFD [6]. We here show
Table 2. Fatty acid profile in WAT and plasma of wildtype and HSL null mice.
Lipid species Genotype 16:0 16:1n7 18:0 18:1n9
WAT TAG Wildtype 16.2860.46 3.7760.19 3.0360.10 58.7660.92
HSL null 16.4960.39 2.7860.12** 3.7460.13** 59.0260.46
p=0.89 p=0.002 p=0.002 p=0.89
Plasma NEFA Wildtype 21.7660.91 4.2260.48 12.4260.84 38.5860.87
HSL null 24.7360.75* 2.9560.26* 17.0660.73** 34.7661.02**
p=0.016 p=0.029 p=0.003 p=0.008
Plasma TAG Wildtype 20.1160.51 2.1260.09 4.4360.68 42.5362.57
HSL null 17.6060.52* 1.3360.18* 4.2460.21 37.1061.00
p=0.010 p=0.018 p=0.74 p=0.068
Values given are means 6 SEM, in g/100 g of total fatty acids. Data were generated on male mice after HFD followed by an overnight fast (12 h) (n=6–12). Differences
between the two genotypes were analyzed using a non-parametric Mann-Whitney U-test. Data were considered significant if p,0.05.
*p,0.05,
**p,0.01.
doi:10.1371/journal.pone.0021603.t002
Figure 3. Altered expression of elongases in white adipocytes from HSL null mice. Level of mRNA of Elovl1 (A), Elovl3 (B), Elovl5 (C) and
Elovl6 (D) analyzed with real-time quantitative PCR in isolated adipocytes from periovarial WAT from 5 months old, overnight fasted wildtype and
HSL null mice fed a HFD (n = 11). Values given are mean 6 SEM, *p,0.05, ***p,0.001, analyzed with Mann-Whitney U tests.
doi:10.1371/journal.pone.0021603.g003
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bound precursor (125 kDa) (0.03, p,0.01) and the active, nuclear
located DNA-binding isoform (68 kDa) (0.11, p,0.01) of
SREBP1c (Figure 7A) and of FAS (0.25, p,0.05) (Figure 7B)
in WAT from HSL null mice fed a HFD.
HSL null mice on a HFD show signs of impaired insulin
sensitivity
HSL null mice generated in our lab show signs of impaired
insulin sensitivity when fed a normal chow diet [2]. To investigate
the impact of diet on the sensitivity to insulin, glucose and insulin
tolerance tests were performed in mice on HFD. The intravenous
glucose tolerance test (IGTT) showed that whereas plasma levels of
glucose (Figure 8A) were similar between the two genotypes,
levels of insulin (Figure 8B) were significantly elevated in HSL
null mice (p,0.05). Also, increased glucose levels in HSL null mice
after an insulin tolerance test (ITT) (p,0.05 and p,0.01)
(Figure 8C), suggest impaired insulin sensitivity in these mice.
Discussion
In this study we report a markedly decreased expression of
SCD1 and 2 in WAT of HSL null mice on a HFD. Decreased
activity of SCDs in WAT is reflected in lowered desaturation ratios
of palmitate and stearate in WAT TAG and plasma NEFA. In the
liver, decreased desaturation of palmitate is seen despite increased
expression of SCD1. Also, elevated mRNA expression of Elovl1 in
WAT from HSL null mice on HFD, possibly underlie the
increased elongation of palmitate observed in WAT TAG and
plasma NEFA.
SCDs are critical regulators of energy metabolism and catalyze
the synthesis of monounsaturated fats, the most important ones
being 16:1n7 and 18:1n9. SCD1 catalyzes the conversion of 18:0
to 18:1n9, a major substrate for triglyceride synthesis, and is
proposed to be required for the development of diet-induced
obesity and insulin resistance [8]. Mice with a global deletion of
SCD1 are resistant to HFD and genetically induced obesity and
are protected against liver steatosis in a number of mouse models
[12,26]. Reduced adiposity is associated with increased insulin
sensitivity [12]. It has recently been suggested that hepatic SCD1
expression, via the generation of oleate, is required for
carbohydrate-induced adiposity, whereas SCD1 inhibition in
extrahepatic tissue is required to protect mice from HFD-induced
obesity and insulin resistance [27]. Mice with liver specific SCD1
deletion show decreased lipogenesis and lower levels of nuclear
SREBP1. In the HSL null mice, a clear connection can be seen
Figure 4. Increased elongation of fatty acids in WAT, plasma and liver of HSL null mice. Ratios of 16:0/14:0 (A) and 18:0/16:0 (B) fatty acids
in epididymal WAT TAG from 5 months old HFD-fed HSL null mice (n=6–12). Ratios of 18:0/16:0 (C) plasma NEFA (n=6–10), and 20:0/18:0 (D) and
20:1n9/18:1n9 (E) fatty acids in plasma TAG (n=3–7) of 5 months old male wildtype and HSL null mice fed HFD. Ratios of 18:0/16:0 (F) and 20:1n9/
18:1n9 (G) fatty acids in liver TAG (n=5–7) of 5 months old female wildtype and HSL null mice fed HFD. Tissues and plasma were collected from mice
after an overnight fast. Values given are mean 6 SEM, *p,0.05, **p,0.01, ***p,0.001, analyzed with Mann-Whitney U tests.
doi:10.1371/journal.pone.0021603.g004
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where SCD1 levels are decreased (Figure 1A), TAG incorpora-
tion is significantly lower [5]. The opposite is seen for the liver
having increased expression of SCD1 [23] and increased
incorporation of TAG [5]. Similar to SCD1 deficient mice [8]
HSL null mice have decreased desaturation index (16:1n7/16:0
and 18:1n9/18:0) in plasma, and also in WAT. In liver of HSL
null mice, however, the proportion of 18:1n9 is increased [23]
possibly mediated by increased SCD1 activity. The accumulation
of 18:1 in the liver is a typical feature of liver steatosis [7].
In cultured 3T3-L1 adipocytes, SCD2 is correlated to and
required for the induction and maintenance of PPARc protein
levels and for adipogenesis [11]. It is suggested that rather than
providing fatty acid signals to PPARc-dependent pathways, SCD2
could be important for the generation of unsaturated FAs
necessary for normal functions of the transcriptional machinery
that drives PPARc expression and also to maintain protein
synthesis rates of PPARc in mature adipocytes. Adipocytes from
HSL null mice on a HFD show markedly decreased (4-fold) levels
of SCD2 (Figure 1B) and lower levels of the master regulators of
adipogenesis i.e. PPARc and C/EBPa [4]. These data are in
agreement with SCD2 being in control of PPARc expression and
adipogenesis. It has been speculated that PPARc plays a role as
fatty acid sensor, allowing proper expression of FA metabolizing
enzymes and the generation of new adipocytes [11]. Differenti-
ating adipocytes can fully synthesize a PPARc ligand, since
preadipocytes will differentiate and produce a PPARc ligand in
the absence of exogenous FAs [28,29]. These findings stress the
importance of endogenously synthesized FAs for adipogenesis.
16:1n7 fatty acid has recently been identified as a potential
lipokine derived from adipose tissue that contributes to the
regulation of global lipid homeostasis [30]. Mice lacking both
FABP4 and 5 (FABP
2/2 mice) are strongly protected from diet-
induced obesity, insulin resistance, type-2 diabetes and liver
steatosis [31]. The adipose tissue of FABP
2/2 mice is resistant to
diet-induced insulin resistance and the lipid profile of adipose
tissue is strikingly enriched in 16:1n7 fatty acid in all major lipid
classes [30]. The suppressive effect of HFD on the level of 16:1n7
in adipose tissue seen in wildtype mice is lost in FABP
2/2 mice.
Also, levels of palmitoleate in plasma NEFA of FABP
2/2 mice
were increased, illustrating the importance of WAT as a source of
circulating free fatty acids. Intriguingly, after a HFD regimen,
TAG in WAT from HSL null mice contains a significantly less
proportion of 16:1n7 fatty acids (Table 2). This could be a
contributing factor to the decreased sensitivity to insulin previously
shown in this tissue [2,5]. Further, circulating levels of 16:1n7 in
plasma NEFA, are significantly decreased, most likely reflecting
lipid metabolism in WAT, and is a possible confounding factor to
the observed systemic decrease in insulin sensitivity of HSL null
mice on HFD (Figure 8).
Hepatic SCD1 activity is dramatically suppressed in FABP
2/2
mice [31]. It has recently been shown that palmitoleate is the main
lipid component contributing to the suppression of SCD1
expression in liver cells [30]. In WAT, a marked stimulation of
FAS, SCD1 and ELOVL6, three principal enzymes mediating de
novo lipogenesis, is seen in FABP
2/2 mice [30]. This highlights
the opposite pattern of expression of SCD1, and other lipogenic
genes in liver vs. adipose tissue of FABP
2/2 mice, likely regulated
by 16:1n7. However, in skeletal muscle of these mice, another
main target of insulin, the regulation of SCD1 activity follows that
of WAT [31]. Also, concentrations of muscle palmitoleate closely
resemble those observed in plasma, which in turn directly reflect
adipose fatty acids [30]. This suggests that palmitoleate liberated
from adipose tissue, is the underlying mechanism for 16:1n7
enrichment in skeletal muscle in FABP
2/2 mice. In agreement
with similar regulation of SCDs in WAT and muscle, are the
previously observed decreased expression levels of SCD1 and 2 in
muscle of HSL null mice [32].
Studies on FABP
2/2 mice have suggested that the majority of
palmitoleate in liver cannot be accounted for by adipose-derived
free fatty acids and that circulating 16:1n7 may instead play a
regulatory role on the lipogenic program of the liver rather than
serving as a substrate to drive TAG synthesis [30]. It has further
been demonstrated that suppression of SCD1 activity is a key
factor determining the liver steatosis phenotype in FABP
2/2 mice.
In the HSL null mice, the opposite scenario of significantly
decreased proportions of palmitoleate in WAT and plasma
prevent a suppression of SCD1 in the liver, resulting in increased
expression levels of liver SCD1. A consequence of this is elevated
proportions of 18:1n9 [23] and increased TAG incorporation
resulting in liver steatosis [5], a possible contributing factor to the
decreased insulin sensitivity observed in HSL null mice on HFD
(Figure 8). Decreased levels of SCD1 and SCD2 in WAT lead to
lower amount of palmitoleate. An absence of lipid chaperons has
been shown to positively regulate de novo lipogenesis in WAT,
disconnecting the normal response of this tissue to a HFD [30].
Although decreased levels of aP2 (FABP4), the major lipid
chaperon in WAT, is seen in HSL null mice fed a HFD [4],
lipogenesis is decreased. It is possible that a total absence of lipid
chaperons is necessary to get an effect on lipogenesis and that the
remaining aP2 and/or other lipid chaperones in WAT are still
able to mediate the negative effect of HFD on SCD1 levels. Also,
severely decreased levels of other transcription factors known to
positively regulate SCD1 expression, e.g. PPARc and SREBP1c,
in WAT of HSL null mice (Figure 7A) [4,5] likely influence the
amount of SCD1 in adipose tissue of HSL null mice.
In WAT from HSL deficient mice, a large increase in the
expression of Elovl1 is seen, which is surprising as this isoform is
previously described to be constitutively expressed [7]. Consistent
with this is an increased elongation of 16:0 to 18:0 in WAT and
plasma from HSL null mice. Proportions of 16:0 are not increased
in WAT from HSL null mice (Table 2) despite markedly
decreased levels of desaturases. Decreased de novo lipogenesis in
WAT, suggested by dramatically decreased protein levels of
SREBP1 and FAS (Figure 7), could counteract the accumulation
of 16:0. Also, increased elongation of 16:0 by Elovl1 in WAT
could help prevent a buildup of 16:0 in favor of 18:0, the latter of
which is significantly increased in WAT (1.23, p,0.01) (Table 2).
Similar to WAT, there is an increased ratio of 18:0/16:0 in the
liver of mice deficient in HSL. Surprisingly, the mRNA levels of
Elovl6 were unchanged between the two genotypes (Table 1).
However, although Elovl6 is shown to account for a majority of
Figure 5. Plasma lipidome analysis by top-down shotgun mass spectrometry of HFD-fed HSL null and wildtype mice. Data are
expressed as % change of a lipid molecular species in HSL null vs. wildtype female mice with values below 100% fold change threshold indicating
decreased amount and values above the 100% fold change threshold suggesting increased amount in HSL null vs. wildtype. Different lipid species are
ranked within each class in descending order according to their absolute abundance in HSL null mice. Data is presented as median value (n=4–6),
*p,0.05, **p,0.01, analyzed with Mann-Whitney U test. No correction for multiple testing was done and by chance only 5.7 (113*0.05) lipid species
would be expected to be differentially expressed between the two genotypes.
doi:10.1371/journal.pone.0021603.g005
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PLoS ONE | www.plosone.org 9 June 2011 | Volume 6 | Issue 6 | e2160316:0 elongation in the liver [25], the increased expression of Elovl1
and 3 seen in the liver of HSL null mice might influence the
elongation of 16:0.
Many models of mice with protection against diet-induced
insulin resistance also display resistance to diet-induced obesity.
However, a few studies showing maintained insulin sensitivity
despite diet-induced obesity and hepatosteatosis exist, e.g. FABP4
and 5 [33,34] as well as Elovl6 [25] deficient mice. The
uncoupling of obesity from insulin resistance, highlights the
importance of tissue fatty acid composition for insulin sensitivity
and further suggests that conversion of palmitate to stearate, and
the desaturation of stearate to oleate are critical events for the
emergence of insulin resistance. HSL deficient mice are protected
against HFD-induced adiposity but not liver steatosis and insulin
Figure 6. Plasma lipidomics reveals differences between HSL null mice and wildtype mice following a HFD. Orthogonal Partial Least
Squares-Discriminant Analysis (OPLS-DA) of plasma lipidomics data was applied to differentiate the HSL null mice on HFD from the control mice with
113 identified lipid species included in the analysis as variables. (A) Score plot illustrating clustering of the samples according to the genotype, with
each data point on the plot representing the individual plasma lipid profile of an animal. (B,C) Loading column plots to visualize the class-separating
lipid species with a T-bar corresponding to the 95% confidence interval. Lipid species decreased (B) and increased (C) in plasma of female HSL null
mice on HFD vs. wildtype littermates.
doi:10.1371/journal.pone.0021603.g006
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PLoS ONE | www.plosone.org 10 June 2011 | Volume 6 | Issue 6 | e21603Figure 7. Decreased levels of lipogenic enzymes in WAT of HSL null mice fed a HFD. Protein levels of SREBP1 (A) and FAS (B), analyzed with
western blot in WAT from 5 months old female wildtype and HSL null mice fed HFD (n=4–7). Values given are mean 6 SEM, *p,0.05, **p,0.01,
analyzed with Mann-Whitney U tests.
doi:10.1371/journal.pone.0021603.g007
Figure 8. HSL null mice on a HFD show signs of impaired insulin sensitivity. Plasma levels of glucose (A) and insulin (B) after an intravenous
glucose tolerance test (IGTT) performed on fasted (6 h) female mice after 24 weeks of HFD (n=5–6). (C) Plasma insulin levels after an insulin tolerance
test (ITT) performed on non-fasted female mice after 18 weeks of HFD (n=6). Values given are mean 6 SEM, *p,0.05, **p,0.01, analyzed with Mann-
Whitney U tests.
doi:10.1371/journal.pone.0021603.g008
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desaturation as an important metabolic controller, regulating the
amount of lipid being stored in various tissues. In WAT, an
absence of HSL, via decreased levels of desaturases, suppresses the
incorporation of FAs into TAG, decreasing lipid storage.
Meanwhile, in the liver, where increased desaturation occurs,
the opposite scenario is seen.
The exact mechanism of how an absence of HSL will affect the
expression of key enzymes involved in lipid metabolism, with
profound effects on the lipid profile, is still unknown. We have
previously suggested that HSL appears to play an important role
in the generation of lipids for transcriptional regulation and
various lipid signaling events [6]. Recently, it has also been
postulated that HSL modulate adipose lipid metabolism by
providing intrinsic ligands or pro-ligands for PPARc [35].
Selective mobilization of fatty acids by HSL according to chain
length and degree of desaturation has also been demonstrated
[36]. As previously speculated in the context of cholesterol
metabolism [23], a cross-talk exists between adipose tissue and
the liver, more pronounced in the fasted state when HSL is
maximally active. By inactivating the gene for HSL, the
communication between WAT and the liver is disturbed, greatly
affecting lipid metabolism in these tissues reflected in the severely
altered plasma lipid profile (Figure 6A). This study supports the
role of 16:1n7 as a possible mediator of this crosstalk between
adipose tissue and liver, and that dysregulation of this mediator
will have profound effects on lipid metabolism and insulin
sensitivity.
In conclusion, this study illustrates the importance of HSL for
normal lipid metabolism in response to a HFD. An absence of
HSL has a great impact on the expression and activity of elongases
and desaturases, resulting in altered lipid profiles in WAT, liver
and plasma. Finally, altered levels of the recently suggested
lipokine palmitoleate in tissue and plasma of HSL null mice, could
be an important factor mediating and contributing to the changed
lipid profile, and possibly also to the decreased insulin sensitivity
seen in HSL null mice on a HFD. Further investigations into the
role of HSL for the generation of lipids involved in crucial
metabolic processes is warranted in order to better understand and
combat the complex processes of obesity and insulin resistance.
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